{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T16:36:14Z","timestamp":1756571774550,"version":"3.41.2"},"reference-count":45,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDR"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Toenail onychomycosis is common in patients with diabetes and it can increase\nthe risk of secondary infections and foot complications. Despite several studies investigating\nthe prevalence and associated factors of toenail onychomycosis from different parts of the world,\nthere are no data from Jordan.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>To determine the prevalence and the associated factors of toenail onychomycosis among\npatients with diabetes in Jordan.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A cross-sectional study was conducted on 375 patients with diabetes at the National\nCentre for Diabetes, Endocrinology, and Genetics in Amman, Jordan. Several socio-demographic\nand health-independent variables including foot self-care practices were collected. Toenail onychomycosis\nwas assessed by a specimen culture and microscopic examinations. Descriptive and\ninferential statistics were used for data analysis.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The prevalence of toenail onychomycosis was 57.6% (n=216). Multiple logistic regression\nrevealed four significant associated factors; the presence of neuropathy (\u03b2=1.87, p=0.02), being\nan ex-smoker (\u03b2=2.69, p=0.01), being treated by both insulin and oral hypoglycemics drugs\n(\u03b2=1.32, p=0.03), and using antibiotics in the last year (\u03b2=1.78, p=0.02).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The prevalence of toenail onychomycosis among patients with diabetes in Jordan is\nhigh. Regular foot screening and podiatric care are recommended especially among patients with\ndiabetic neuropathy, current treatment by insulin and oral hypoglycemics drugs, previous history of\nsmoking, and previous use of antibiotics.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573399819666230403132241","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T04:48:02Z","timestamp":1680670082000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and Associated Factors of Toenail Onychomycosis Among\nPatients with Diabetes in Jordan"],"prefix":"10.2174","volume":"20","author":[{"given":"Hesham","family":"Alrauosh","sequence":"first","affiliation":[{"name":"Prince Hamzah Hospital, Amman, Jordan"},{"name":"The National Centre for Diabetes, Endocrinology, and Genetics, Amman,\nJordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8044-3554","authenticated-orcid":true,"given":"Anas","family":"Ababneh","sequence":"additional","affiliation":[{"name":"Faculty of Nursing, Applied Science Private University, Amman, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5447-5245","authenticated-orcid":true,"given":"Faris G.","family":"Bakri","sequence":"additional","affiliation":[{"name":"The National Centre for Diabetes, Endocrinology, and Genetics, Amman,\nJordan"},{"name":"Department of Medicine, Division of\nInfectious Diseases, Jordan University Hospital, Amman, Jordan"},{"name":"Infectious Diseases and Vaccine Center, University\nof Jordan, Amman, Jordan"},{"name":"Faculty of Medicine, University of Jordan, Amman, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mousa","family":"Abujbara","sequence":"additional","affiliation":[{"name":"The National Centre for Diabetes, Endocrinology, and Genetics, Amman,\nJordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hashem","family":"Kanaan","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Jordan\nUniversity of Science and Technology, Irbid, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2462-9068","authenticated-orcid":true,"given":"Nidal A.","family":"Younes","sequence":"additional","affiliation":[{"name":"The National Centre for Diabetes, Endocrinology, and Genetics, Amman,\nJordan"},{"name":"Faculty of Medicine, University of Jordan, Amman, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"Sun H.","year":"2022","unstructured":"Sun H.; Saeedi P.; Karuranga S.; IDF diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract  2022,183,109119","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13410-022-01092-1","author":"Alqahtani B.","year":"2022","unstructured":"Alqahtani B.; Elnaggar R.K.; Alshehri M.M.; Khunti K.; Alenazi A.; National and regional prevalence rates of diabetes in Saudi Arabia: Analysis of national survey data. Int J Diabetes Dev Ctries  2022,1-6","journal-title":"Int J Diabetes Dev Ctries"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/dme.13894","volume":"36","author":"Ajlouni K.","year":"2019","unstructured":"Ajlouni K.; Batieha A.; Jaddou H.; Time trends in diabetes mellitus in Jordan between 1994 and 2017. Diabet Med  2019,36(9),1176-1182","journal-title":"Diabet Med"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"s3","DOI":"10.1097\/01.hjr.0000368191.86614.5a","volume":"17","author":"Susan V.D.","year":"2010","unstructured":"Susan V.D.; Beulens J.W.; Yvonne T.; The global burden of diabetes and its complications: An emerging pandemic. Eur J Cardiovasc Prev Rehabil  2010,17(1),s3-s8","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pcd.2020.08.002","volume":"15","author":"Pal R.","year":"2021","unstructured":"Pal R.; Banerjee M.; Are people with uncontrolled diabetes mellitus at high risk of reinfections with COVID-19? Prim Care Diabetes  2021,15(1),18-20","journal-title":"Prim Care Diabetes"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.dld.2020.10.022","volume":"53","author":"Rosenblatt R.","year":"2021","unstructured":"Rosenblatt R.; Atteberry P.; Tafesh Z.; Uncontrolled diabetes mellitus increases risk of infection in patients with advanced cirrhosis. Dig Liver Dis  2021,53(4),445-451","journal-title":"Dig Liver Dis"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1468-3083.2009.03225.x","volume":"23","author":"Cathcart S.","year":"2009","unstructured":"Cathcart S.; Cantrell W.; Elewski B.E.; Onychomycosis and diabetes. J Eur Acad Dermatol Venereol  2009,23(10),1119-1122","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/ijd.13402","volume":"56","author":"Oz Y.","year":"2017","unstructured":"Oz Y.; Qoraan I.; Oz A.; Balta I.; Prevalence and epidemiology of tinea pedis and toenail onychomycosis and antifungal susceptibility of the causative agents in patients with type 2 diabetes in Turkey. Int J Dermatol  2017,56(1),68-74","journal-title":"Int J Dermatol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S0255-0857(21)01924-1","volume":"26","author":"Kaur R.","year":"2008","unstructured":"Kaur R.; Kashyap B.; Bhalla P.; Onychomycosis--epidemiology, diagnosis and management. Indian J Med Microbiol  2008,26(2),108-116","journal-title":"Indian J Med Microbiol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"370","DOI":"10.7547\/17-006","volume":"108","author":"Cunha N.","year":"2018","unstructured":"Cunha N.; Galhardas C.; Apetato M.; Lencastre A.; Toenail changes in patients with diabetes mellitus with and without onychomycosis. J Am Podiatr Med Assoc  2018,108(5),370-374","journal-title":"J Am Podiatr Med Assoc"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13047-020-00383-2","volume":"13","author":"Armstrong D.G.","year":"2020","unstructured":"Armstrong D.G.; Swerdlow M.A.; Armstrong A.A.; Conte M.S.; Padula W.V.; Bus S.A.; Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer. J Foot Ankle Res  2020,13(1),16","journal-title":"J Foot Ankle Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1111\/jdv.12873","volume":"29","author":"Gupta A.K.","year":"2015","unstructured":"Gupta A.K.; Daigle D.; Foley K.A.; The prevalence of culture-confirmed toenail onychomycosis in at-risk patient populations. J Eur Acad Dermatol Venereol  2015,29(6),1039-1044","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=13","first-page":"84","volume":"18","author":"Al-Mutairi N.","year":"2010","unstructured":"Al-Mutairi N.; Eassa B.I.; Al-Rqobah D.A.; Clinical and mycologic characteristics of onychomycosis in diabetic patients. Acta Dermatovenerol Croat  2010,18(2),84-91","journal-title":"Acta Dermatovenerol Croat"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jcjd.2020.11.011","volume":"45","author":"Aronson R.","year":"2021","unstructured":"Aronson R.; Chu L.; Joseph N.; Brown R.; Prevalence and risk evaluation of diabetic complications of the foot among adults with type 1 and type 2 diabetes in a large Canadian population (PEDAL study). Can J Diabetes  2021,45(7),588-593","journal-title":"Can J Diabetes"},{"key":"ref=15","first-page":"659","volume":"99","author":"Assadamongkol R.","year":"2016","unstructured":"Assadamongkol R.; Lertwattanarak R.; Wannachalee T.; Bunyaratavej S.; Leeyaphan C.; Matthapan L.; Prevalence, risk factors, and type of organism in fungal foot infection and toenail onychomycosis in Thai diabetic patients. J Med Assoc Thai  2016,99(6),659-664","journal-title":"J Med Assoc Thai"},{"key":"ref=16","first-page":"891","volume":"32","author":"Akkus G.","year":"2016","unstructured":"Akkus G.; Evran M.; Gungor D.; Karakas M.; Sert M.; Tetiker T.; Tinea pedis and onychomycosis frequency in diabetes mellitus patients and diabetic foot ulcers. A cross sectional - observational study. Pak J Med Sci  2016,32(4),891-895","journal-title":"Pak J Med Sci"},{"key":"ref=17","first-page":"30","volume":"4","author":"Baiu S.H.","year":"2016","unstructured":"Baiu S.H.; Bridan W.M.; Kalfa H.M.K.; Fungi as pathogens of onychomycosis among diabetic patients. J Appl Environ Microbiol  2016,4(2),30-33","journal-title":"J Appl Environ Microbiol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"64","DOI":"10.4093\/jkda.2006.30.1.64","volume":"30","author":"Cha B.Y.","year":"2006","unstructured":"Cha B.Y.; Son H.S.; Lee J.M.; Kang S.K.; Prevalence of fungal infection on foot in diabetic patients and correlation between diabetic ulcer and fungal infection on foot. Journal of Korean Diabetes Association  2006,30(1),64-72","journal-title":"Journal of Korean Diabetes Association"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13098-016-0176-y","volume":"8","author":"de Macedo G.M.C.","year":"2016","unstructured":"de Macedo G.M.C.; Nunes S.; Barreto T.; Skin disorders in diabetes mellitus: An epidemiology and physiopathology review. Diabetol Metab Syndr  2016,8(1),63","journal-title":"Diabetol Metab Syndr"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1186\/s13104-016-2302-1","volume":"9","author":"Eba M.","year":"2016","unstructured":"Eba M.; Njunda A.L.; Mouliom R.N.; Onychomycosis in diabetic patients in Fako Division of Cameroon: Prevalence, causative agents, associated factors and antifungal sensitivity patterns. BMC Res Notes  2016,9(1),494","journal-title":"BMC Res Notes"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"6099","DOI":"10.4081\/dr.2015.6099","volume":"7","author":"Elbendary A.","year":"2015","unstructured":"Elbendary A.; El Tawdy A.; Zaki N.; Alfishawy M.; Rateb A.; Subclinical onychomycosis in patients with type II diabetes. Dermatol Rep  2015,7(3),6099","journal-title":"Dermatol Rep"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.7547\/1010049","volume":"101","author":"Gulcan A.","year":"2011","unstructured":"Gulcan A.; Gulcan E.; Oksuz S.; Sahin I.; Kaya D.; Prevalence of toenail onychomycosis in patients with type 2 diabetes mellitus and evaluation of risk factors. J Am Podiatr Med Assoc  2011,101(1),49-54","journal-title":"J Am Podiatr Med Assoc"},{"key":"ref=23","first-page":"479","volume":"44","author":"Leelavathi M.","year":"2013","unstructured":"Leelavathi M.; Azimah M.N.; Kharuddin N.F.; Tzar M.N.; Prevalence of toenail onychomycosis among diabetics at a primary care facility in Malaysia. Southeast Asian J Trop Med Public Health  2013,44(3),479-483","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.riam.2012.09.007","volume":"30","author":"Parada H.","year":"2013","unstructured":"Parada H.; Ver\u00edssimo C.; Brand\u00e3o J.; Dermatomycosis in lower limbs of diabetic patients followed by podiatry consultation. Rev Iberoam Micol  2013,30(2),103-108","journal-title":"Rev Iberoam Micol"},{"key":"ref=25","first-page":"1","volume":"3","author":"Rathur H.","year":"2015","unstructured":"Rathur H.; Housley A.; The incidence of asymptomatic onychomycosis in diabetes mellitus. Clin Res Foot Ankle  2015,3(2),1-3","journal-title":"Clin Res Foot Ankle"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2340\/00015555-0113","volume":"86","author":"Saunte D.M.L.","year":"2006","unstructured":"Saunte D.M.L.; Holgersen J.B.; H\u00e6dersdal M.; Prevalence of toe nail onychomycosis in diabetic patients. Acta Derm Venereol  2006,86(5),425-428","journal-title":"Acta Derm Venereol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5693\/djo.01.2008.013","volume":"14","author":"Al-Amer R.M.","year":"2008","unstructured":"Al-Amer R.M.; Khader Y.; Malas S.; Abu-Yaghi N.; Al-Bdour M.; Ajlouni K.; Prevalence and risk factors of diabetic retinopathy among Jordanian patients with type 2 diabetes. Digit J Ophthalmol  2008,14,42-49","journal-title":"Digit J Ophthalmol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2174\/1573399812666151210143140","volume":"13","author":"AlAyed M.","year":"2017","unstructured":"AlAyed M.; Younes N.; Al-Smady M.; Khader Y.; Robert A.; Ajlouni K.; Prevalence of foot ulcers, foot at risk and associated risk factors among Jordanian diabetics. Curr Diabetes Rev  2017,13(2),182-191","journal-title":"Curr Diabetes Rev"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13098-017-0304-3","volume":"10","author":"Khawaja N.","year":"2018","unstructured":"Khawaja N.; Abu-Shennar J.; Saleh M.; Dahbour S.S.; Khader Y.S.; Ajlouni K.M.; The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan. Diabetol Metab Syndr  2018,10(1),1-10","journal-title":"Diabetol Metab Syndr"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2174\/1573399815666191001101910","volume":"16","author":"Ababneh A.","year":"2020","unstructured":"Ababneh A.; Bakri F.G.; Khader Y.; Lazzarini P.; Ajlouni K.; Prevalence and associates of foot deformities among patients with diabetes in Jordan. Curr Diabetes Rev  2020,16(5),471-482","journal-title":"Curr Diabetes Rev"},{"key":"ref=31","first-page":"118","volume":"46","author":"Bakri F.G.","year":"2012","unstructured":"Bakri F.G.; Allan A.H.; Khader Y.S.; Younes N.A.; Ajlouni K.M.; Prevalence of diabetic foot ulcer and its associated risk factors among diabetic patients in Jordan. J Med J  2012,46(2),118-125","journal-title":"J Med J"},{"key":"ref=32","first-page":"9","volume":"1","author":"Naing L.","year":"2006","unstructured":"Naing L.; Winn T.; Rusli B.; Practical issues in calculating the sample size for prevalence studies. Arch Orofac Sci  2006,1,9-14","journal-title":"Arch Orofac Sci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.2337\/dc15-S005","volume":"38","year":"2015","unstructured":"(2) Classification and diagnosis of diabetes. Diabetes Care American Diabetes Association 2015,38(Suppl. 1),S8-S16","journal-title":"Diabetes Care"},{"journal-title":"Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO\/IDF consultation","year":"2006","key":"ref=34","unstructured":"Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO\/IDF consultation World Health Organization\/International Diabetes Federation 2006"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"S181","DOI":"10.1002\/dmrr.848","volume":"24","author":"Apelqvist J.","year":"2008","unstructured":"Apelqvist J.; Bakker K.; van Houtum W.H.; Schaper N.C.; Practical guidelines on the management and prevention of the diabetic foot. Diabetes Metab Res Rev  2008,24(S1),S181-S187","journal-title":"Diabetes Metab Res Rev"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1001\/archderm.136.9.1112","volume":"136","author":"Lawry M.A.","year":"2000","unstructured":"Lawry M.A.; Haneke E.; Strobeck K.; Martin S.; Zimmer B.; Romano P.S.; Methods for diagnosing onychomycosis: A comparative study and review of the literature. Arch Dermatol  2000,136(9),1112-1116","journal-title":"Arch Dermatol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1046\/j.1365-4362.1997.00349.x","volume":"36","author":"Gupta A.","year":"1997","unstructured":"Gupta A.; Jain H.; Lynde C.; Watteel G.; Summerbell R.; Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists\u2019 offices in Ontario, Canada - a multicenter survey of 2001 patients. Int J Dermatol  1997,36(10),783-787","journal-title":"Int J Dermatol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"J258","DOI":"10.1016\/j.jaut.2009.12.003","volume":"34","author":"Arnson Y.","year":"2010","unstructured":"Arnson Y.; Shoenfeld Y.; Amital H.; Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun  2010,34(3),J258-J265","journal-title":"J Autoimmun"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"101044","DOI":"10.1016\/j.molmet.2020.101044","volume":"39","author":"Erener S.","year":"2020","unstructured":"Erener S.; Diabetes, infection risk and COVID-19. Mol Metab  2020,39,101044","journal-title":"Mol Metab"},{"key":"ref=40","first-page":"1028","volume":"65","author":"Atreja A.","year":"2015","unstructured":"Atreja A.; Kalra S.; Infections in diabetes. J Pak Med Assoc  2015,65(9),1028-1030","journal-title":"J Pak Med Assoc"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1017\/ice.2015.249","volume":"37","author":"Martin E.T.","year":"2016","unstructured":"Martin E.T.; Kaye K.S.; Knott C.; Diabetes and risk of surgical site infection: A systematic review and meta-analysis. Infect Control Hosp Epidemiol  2016,37(1),88-99","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/0002-9343(57)90023-2","volume":"22","author":"Torack R.M.","year":"1957","unstructured":"Torack R.M.; Fungus infections associated with antibiotic and steroid therapy. Am J Med  1957,22(6),872-882","journal-title":"Am J Med"},{"key":"ref=43","first-page":"651","volume":"66","author":"Mohsen S.","year":"2020","unstructured":"Mohsen S.; Dickinson J.A.; Somayaji R.; Update on the adverse effects of antimicrobial therapies in community practice. Can Fam Physician  2020,66(9),651-659","journal-title":"Can Fam Physician"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13613-021-00923-4","volume":"11","author":"Montrucchio G.","year":"2021","unstructured":"Montrucchio G.; Lupia T.; Lombardo D.; Risk factors for invasive aspergillosis in ICU patients with COVID-19: Current insights and new key elements. Ann Intensive Care  2021,11(1),136","journal-title":"Ann Intensive Care"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.chom.2018.11.003","volume":"24","author":"Li X.","year":"2018","unstructured":"Li X.; Leonardi I.; Semon A.; Doron I.; Response to fungal dysbiosis by gut-resident CX3CR1+ mononuclear phagocytes aggravates allergic airway disease. Cell Host and Microbe  2018,24(6),847-856","journal-title":"Cell Host and Microbe"}],"container-title":["Current Diabetes Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573399819666230403132241","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/215425\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573399819666230403132241","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T17:04:23Z","timestamp":1708621463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/215425\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573399819666230403132241","relation":{},"ISSN":["1573-3998"],"issn-type":[{"type":"print","value":"1573-3998"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-08-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e030423215425"}}